New PSA guides misleading for GPs?
Professor Mark Frydenberg, vice-president of the Urological Society of Australia and New Zealand, said GPs could be scared away from recommending potentially lifesaving prostate cancer tests because the resource does not reflect current practice.
Prostate Specific Antigen (PSA) Testing for Prostate Cancer in Asymptomatic Men: Information for Health Practitioners was released by the NHMRC to outline the risks and benefits of PSA testing.
Ground-breaking consensus guidelines on PSA testing and management of test-detected prostate cancer are expected to be released later this year, a process strongly supported by Professor Frydenberg, who is a member of the multidiscipline expert advisory group.
But he believes some men may die unnecessarily by failing to have the test because the GP-focused NHMRC resource is open to interpretation.